Safety, PK, and PD of recombinant anti-interleukin-21 monoclonal antibody in a first-in-human trial

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Safety, PK, and PD of recombinant anti-interleukin-21 monoclonal antibody in a first-in-human trial
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
Volume 54, Issue 04, Pages 243-252
Publisher
Dustri-Verlgag Dr. Karl Feistle
Online
2016-02-02
DOI
10.5414/cp202474

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.